FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

POINT BIOPHARMA GLOBAL INC.: capex

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/44a3efb2-7702-44e6-b975-370076903dc3

Reported value

$940.931k{"amount": 940931, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
POINT BIOPHARMA GLOBAL INC.
Metric
capex
Period
2022-01-01 – 2022-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001811764-22-000050 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:14:23.418470+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001811764/capex/2022-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.